Slavin JL - Search Results

1

Differential expression of GLUT12 in breast cancer and normal breast tissue.

Rogers S, Docherty SE, Slavin JL, Henderson MA, Best JD. Rogers S, et al. Among authors: slavin jl. Cancer Lett. 2003 Apr 25;193(2):225-33. doi: 10.1016/s0304-3835(03)00010-7. Cancer Lett. 2003. PMID: 12706881

2

Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer.

Sharp JA, Sung V, Slavin J, Thompson EW, Henderson MA. Sharp JA, et al. Lab Invest. 1999 Jul;79(7):869-77. Lab Invest. 1999. PMID: 10418827

3

Parathyroid hormone-related protein production by breast cancers, improved survival, and reduced bone metastases.

Henderson M, Danks J, Moseley J, Slavin J, Harris T, McKinlay M, Hopper J, Martin T. Henderson M, et al. J Natl Cancer Inst. 2001 Feb 7;93(3):234-7. doi: 10.1093/jnci/93.3.234. J Natl Cancer Inst. 2001. PMID: 11158193 No abstract available.

4

Expression and localization of GLUT1 and GLUT12 in prostate carcinoma.

Chandler JD, Williams ED, Slavin JL, Best JD, Rogers S. Chandler JD, et al. Among authors: slavin jl. Cancer. 2003 Apr 15;97(8):2035-42. doi: 10.1002/cncr.11293. Cancer. 2003. PMID: 12673735 Free article.

5

Associations between liver histology and severity of the metabolic syndrome in subjects with nonalcoholic fatty liver disease.

Ryan MC, Wilson AM, Slavin J, Best JD, Jenkins AJ, Desmond PV. Ryan MC, et al. Diabetes Care. 2005 May;28(5):1222-4. doi: 10.2337/diacare.28.5.1222. Diabetes Care. 2005. PMID: 15855597 No abstract available.

6

Parathyroid hormone-related protein localization in breast cancers predict improved prognosis.

Henderson MA, Danks JA, Slavin JL, Byrnes GB, Choong PF, Spillane JB, Hopper JL, Martin TJ. Henderson MA, et al. Among authors: slavin jl. Cancer Res. 2006 Feb 15;66(4):2250-6. doi: 10.1158/0008-5472.CAN-05-2814. Cancer Res. 2006. PMID: 16489028

7

Osteoprotegerin overexpression by breast cancer cells enhances orthotopic and osseous tumor growth and contrasts with that delivered therapeutically.

Fisher JL, Thomas-Mudge RJ, Elliott J, Hards DK, Sims NA, Slavin J, Martin TJ, Gillespie MT. Fisher JL, et al. Among authors: slavin j. Cancer Res. 2006 Apr 1;66(7):3620-8. doi: 10.1158/0008-5472.CAN-05-3119. Cancer Res. 2006. PMID: 16585187

8

Mesenchymal-to-epithelial transition facilitates bladder cancer metastasis: role of fibroblast growth factor receptor-2.

Chaffer CL, Brennan JP, Slavin JL, Blick T, Thompson EW, Williams ED. Chaffer CL, et al. Among authors: slavin jl. Cancer Res. 2006 Dec 1;66(23):11271-8. doi: 10.1158/0008-5472.CAN-06-2044. Cancer Res. 2006. PMID: 17145872

9

The management of primary cutaneous melanoma in Victoria in 1996 and 2000.

Kelly JW, Henderson MA, Thursfield VJ, Slavin J, Ainslie J, Giles GG. Kelly JW, et al. Med J Aust. 2007 Nov 5;187(9):511-4. doi: 10.5694/j.1326-5377.2007.tb01392.x. Med J Aust. 2007. PMID: 17979616

10

Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer.

Parker BS, Ciocca DR, Bidwell BN, Gago FE, Fanelli MA, George J, Slavin JL, Möller A, Steel R, Pouliot N, Eckhardt B, Henderson MA, Anderson RL. Parker BS, et al. Among authors: slavin jl. J Pathol. 2008 Feb;214(3):337-46. doi: 10.1002/path.2265. J Pathol. 2008. PMID: 17985332

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

249 results

Search Page

Filters